-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026548-hershberger-final-report-2022.pdf
January 01, 2022 - in medical settings
and has been demonstrated to be effective in reducing illicit drug (including opioid … Diagnosing and tracking opioid dependence. J
Fam Pract. 2012; 61(10): 588-597.
22. … Opioid addiction and abuse in
primary care practice: A comparison of methadone and buprenorphine as … Emergency Department–initiated buprenorphine/naloxone
treatment for opioid dependence: A randomized
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
January 01, 2017 - For example, the most common combination that was presented
was for fentanyl or opioid products with … Classifications for Ibuprofen
Therapeutic Class
Code
Description
N02AJ08 Opioids in combination with non-opioid … M01AE51 Propionic acid derivatives: ibuprofen combinations
N02AJ19 Opioids in combination with non-opioid
-
digital.ahrq.gov/sites/default/files/docs/citation/u18hs026154-crane-final-report-2023.pdf
January 01, 2023 - PROs to those with MCC including
respiratory items for PWH with COPD, and Narcan items for those with opioid … 59.9 5.1 (+4.3)
Former 22.5 21.9, 23.1 29.9 29.3, 30.6
Current 11.0 10.5, 11.4 10.9 10.4, 11.3
Opioid … sex, race/ethnicity and geographic location, PWH reporting past or
current cocaine/crack, illicit opioid … was associated with:
higher depression symptoms (−0.9 points (95%CI:-1.4 to −0.4)); recent illicit opioid … While PWH endorsing
depression symptoms, recent opioid use, condomless sex, or multiple sex partners
-
digital.ahrq.gov/program-overview/research-reports/2021-year-review/research-overview
January 01, 2021 - existing electronic health record systems may improve provider use and accessibility, reduce high-risk opioid … prescribing practices, and improve opioid-related overdose outcomes.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
January 01, 2018 - Alerts for Opioids
This study examined trends in drug-allergy interaction (DAI) alert overrides for opioid … We conducted an observational analysis of the DAI opioid alerts triggered
over the last decade (2004 … Allergic reactions included a high proportion (38.2%) of non-immune mediated
opioid reactions (e.g … High override rate for opioid drug-allergy interaction alerts: current
trends and recommendations for
-
digital.ahrq.gov/2020-year-review/research-dissemination/disseminating-knowledge-and-research-findings-conferences
January 01, 2020 - Tools for Chronic Pain in Primary Care
Panel Presentation: Actionable Opportunities for Improving Opioid
-
digital.ahrq.gov/sites/default/files/docs/page/prescribing-patterns-of-cost-effective-drugs-quick-reference-guide.pdf
April 01, 2009 - Choosing Non Opioid Analgesics for
Osteoarthritis. Pub. No. 06(07) EHC009 3.
January 2007.
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015135-arora-final-report-2008.pdf
January 01, 2008 - treatment providers in Northern New Mexico and in
Albuquerque indicates that 85-90% of those receiving opioid … exchange programs have been implemented in New Mexico, there are still communities that do
not provide opioid … detoxification or opioid replacement programs. … and have become
trained and certified in the administration of buprenorphine for the treatment of opioid
-
digital.ahrq.gov/sites/default/files/docs/resource/final-b14-archives-sarkar2075.pdf
January 01, 2013 - Endoscopy Class, which is
intended for medically stable patients without active substance abuse or opioid … patient is medically stable for moderate sedation, does not
abuse substances, and does not routinely use opioid … This patient has significant comorbidities, abuses substances, uses opioid pain
medications regularly
-
digital.ahrq.gov/sites/default/files/docs/cds-authoring-tool-qas-020719.pdf
December 08, 2017 - This approach is
detailed in the 2017 CDS Connect Pilot Report as well as CDC’s Opioid Prescribing … sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
http://build.fhir.org/ig/cqframework/opioid-cds … /service-documentation.html#solution5
http://build.fhir.org/ig/cqframework/opioid-cds/service-documentation.html
-
digital.ahrq.gov/ahrq-funded-projects/automated-adverse-drug-event-detection-and-intervention/annual-summary/2008
January 01, 2008 - Computerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional
-
digital.ahrq.gov/2020-year-review/research-spotlight
January 01, 2020 - management of 70 diseases, covering diabetes, HIV, mental and substance use disorders, chronic pain, opioid
-
digital.ahrq.gov/sites/default/files/docs/citation/r13hs028546-kennedy-final-report-2022.pdf
January 01, 2022 - Prior to working on the front
line of the opioid use disorder crisis, he served as the Chief Medical … Prior to working on the front line of the opioid use disorder crisis, he served as the
Chief Medical
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024004-bajaj-final-report-2017.pdf
January 01, 2017 - discharge MELD, discharge sodium, discharge albumin, discharge HE, discharge
rifaximin use, discharge opioid … ascites (n=4), hepatic hydrothorax (n=1),
upper GI bleeding (n=2), chest pain (n=1), anemia (n=1), opioid
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs022666-weckmann-final-report-2016.pdf
January 01, 2016 - Using the EMR to identify and screen patients at risk for delirium - Final Report
Final Progress Report
R18 HS022666
PI: Weckmann
1
Title: Using the EMR to identify and screen patients at risk for delirium
Principal Investigator and team members:
Michelle Weckmann, MD (PI)
Ryan Carnahan, Pharm D
Grac…
-
digital.ahrq.gov/sites/default/files/docs/citation/shareable-cds-efficiencies-final-report.pdf
December 01, 2019 - Opioid side effects may lengthen the
patient’s hospital stay. … differences between artifacts below:
Site 1: Concurrent Use of Opioids and Benzodiazepines
The opioid … Use of Opioids and Benzodiazepines is an L3 artifact that
provides a recommendation to revise an opioid … This artifact supported a larger system initiative to build from an EHR vendor
Opioid Toolkit with … For example, Site 1 selected the opioid artifact to fill a gap in their
existing opioid package.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022335-juckett-final-report-2017.pdf
January 01, 2017 - specific drug
types that could be consolidated into 23 general categories given by: Analgesic non-opioid … ;
analgesic opioid; anti-anxiety; anti-depressant; anti-histamine; anti-hypertensive; anti-
infective … With the opioid catastrophe
gripping medical practice, we need all the tools possible to help primary … Outcomes Associated with Opioid
Use. In: American Association of Pain Medicine Annual Meeting.
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year4-final-report-2020.pdf
January 01, 2020 - Connect’s work on the
Pain Management Summary application during a panel about leveraging CDS to address opioid … Identified Pain Management Resources
5.1 Patient-Centered Pain Assessment
5.2 Opioid Avoidance
5.3 … Identification of At-Risk Individuals
5.4 Opioid Dose Reduction
5.5 Opioid Use Disorder Treatment … Identified Pain Management CDS Efforts
6.1 Patient-Centered Pain Assessment
6.2 Opioid Avoidance
6.3 … Identifying At-Risk Individuals
6.4 Dose Reduction
6.5 Opioid Use Disorder Treatment
7.
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
January 01, 2019 - The project PL participated in a panel presentation titled, “From Evidence to
Action: Enabling Opioid … Release Rate When
Starting Opioid Therapy
CDC
Structured
09/27/2018
Recommendation #5 - Lowest … Effective Dose CDC Structured 04/23/2017
Recommendation #7 - Opioid Therapy Risk
Assessment
CDC … primary-care-tobacco-assessment-and-cessation-counseling-documentation-template
https://cds.ahrq.gov/cdsconnect/artifact/recommendation-4-opioid-release-rate-when-starting-opioid-therapy … https://cds.ahrq.gov/cdsconnect/artifact/recommendation-4-opioid-release-rate-when-starting-opioid-therapy
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs025443-abraham-final-report-2020.pdf
January 01, 2020 - inclusion in the model were classification as IV fluid, anticoagulant, benzodiazepines,
chemotherapy, opioid … categorizations as an anticoagulant (OR = 0.462; p < 0.001), benzodiazepine (OR = 0.433; p < 0.001),
opioid